Literature DB >> 21663520

Association between single-nucleotide polymorphisms in pre-miRNAs and the risk of asthma in a Chinese population.

Xiao-Wei Su1, Yan Yang, Mei-Li Lv, Li-Juan Li, Wei Dong, Lin-Bo Gao, Hai-Bo Luo, Rui-Juan Cong, Wei-Bo Liang, Ying-Bi Li.   

Abstract

Single-nucleotide polymorphisms (SNPs) in pre-miRNAs may alter microRNA (miRNA) expression levels or processing and contribute to susceptibility to a wide range of diseases. We investigated the correlation between four SNPs (rs11614913, rs3746444, rs2910164, and rs229283) in pre-miRNAs and the risk of asthma in 220 asthma patients and 540 controls using polymerase chain reaction-restriction fragment length polymorphism methodology and DNA-sequencing. There were significant differences in the genotype and allelic distribution of rs2910164G/C and rs2292832C/T polymorphisms among cases and controls. The CC genotype and C allele of rs2910164G/C were significantly associated with a decreased risk of asthma (CC vs. GG, odds ratio [OR] = 0.51, 95% confidence interval [CI]: 0.31-0.82; C vs. G, OR = 0.74, 95% CI: 0.59-0.93). Similarly, the TT genotype and T allele of rs2292832C/T were significantly associated with a decreased risk of asthma (TT vs. CC, OR = 0.56, 95% CI: 0.33-0.95; T vs. C, OR = 0.71, 95% CI: 0.53-0.95). However, no significant association between the other two polymorphisms (i.e., rs11614913C/T and rs3746444C/T) and the risk of asthma was observed. Our data indicate that rs2910164G/C and rs2292832C/T may play a role in the development of asthma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21663520     DOI: 10.1089/dna.2010.1164

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  12 in total

1.  Genetic polymorphisms in pre-microRNAs and risk of ischemic stroke in a Chinese population.

Authors:  Yun Liu; Ying Ma; Bo Zhang; Shun-Xian Wang; Xiao-Ming Wang; Ju-Ming Yu
Journal:  J Mol Neurosci       Date:  2013-11-01       Impact factor: 3.444

Review 2.  Epigenetics in Asthma.

Authors:  Jose L Gomez
Journal:  Curr Allergy Asthma Rep       Date:  2019-11-27       Impact factor: 4.806

Review 3.  MicroRNAs in Allergic Disease.

Authors:  Eishika Dissanayake; Yuzaburo Inoue
Journal:  Curr Allergy Asthma Rep       Date:  2016-09       Impact factor: 4.806

4.  Association study of genetic variants in miRNAs in patients with inflammatory bowel disease: preliminary results.

Authors:  Maria Gazouli; Ioannis Papaconstantinou; Konstantinos Stamatis; Anna Vaiopoulou; Christos Zeglinas; Ioannis Vassiliou; Georgios Giokas; Charalampos Tzathas
Journal:  Dig Dis Sci       Date:  2013-03-30       Impact factor: 3.199

5.  Association of the miR-196a2, miR-146a, and miR-499 Polymorphisms with Asthma Phenotypes in a Korean Population.

Authors:  Hoang Kim Tu Trinh; Duy Le Pham; Su-Chin Kim; Ri-Yeon Kim; Hae-Sim Park; Seung-Hyun Kim
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

Review 6.  MicroRNA regulation of allergic inflammation and asthma.

Authors:  Heather H Pua; K Mark Ansel
Journal:  Curr Opin Immunol       Date:  2015-08-05       Impact factor: 7.486

Review 7.  Epigenetics and childhood asthma: current evidence and future research directions.

Authors:  Muhammad T Salam; Ying Zhang; Kohinoor Begum
Journal:  Epigenomics       Date:  2012-08       Impact factor: 4.778

8.  Precursor miR-499a Variant but not miR-196a2 is Associated with Rheumatoid Arthritis Susceptibility in an Egyptian Population.

Authors:  Eman A Toraih; Nesreen M Ismail; Ahmed A Toraih; Mohammad H Hussein; Manal S Fawzy
Journal:  Mol Diagn Ther       Date:  2016-06       Impact factor: 4.074

Review 9.  Novel insights into miRNA in lung and heart inflammatory diseases.

Authors:  Amit Kishore; Jana Borucka; Jana Petrkova; Martin Petrek
Journal:  Mediators Inflamm       Date:  2014-05-27       Impact factor: 4.711

Review 10.  MicroRNAs: new insights into chronic childhood diseases.

Authors:  Ahmed Omran; Dalia Elimam; Fei Yin
Journal:  Biomed Res Int       Date:  2013-06-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.